 |
|
Biocompatibles expands into US
Biocompatibles, a Farnham-based medical technology company, is set to takeover BrachySciences, a medical device business located in Oxford, Connecticut, in a deal worth $21.6 million (£10.9 million).
The acquisition will enable Biocompatibles to expand into the US, raising its profile among US cancer physicians and companies. The Surrey business will pay an initial $8.6 million on completion with a further $12 million conditional on performance.
The bolt-on acquisition is part of Biocompatibles’ strategy of broadening its delivery of minimally invasive local procedures in the treatment of cancer. The acquired company markets implantable “seeds” that deliver radiation in the treatment of prostate cancer while Biocampatibles produces drug-eluting bead products, also a non-surgical procedure.
To December 2007, BrachySciences made a $200,000 profit on a turnover of $9.7 million.
Simon Crispin, Biocompatibles chief executive, said: “BrachySciences fits well with our business strategy and our commitment to growing revenues and establishing sustainable profitability.”
Other M&A Deals
- Close Brothers adds chemical
firm to portfolio Sep 03 2008 - Resaca returns to Texas
with AIM cash Jul 17 2008 - REM Probe celebrates new windfall Oct 09 2008
- Spice takes the plunge with Morrel Oct 13 2008
Special Offers
- 2008 AIM Guide: Jul 17 2007
- Growth Company Investor Magazine: Jul 17 2007
- Cash Shells 2007 - Research report Jul 17 2007
- Venture Capital Trusts Jul 04 2007
M&A News
- The Capita Group acquires ABS Network Solutions Oct 13 2008
- Europe first to recover, says report Oct 13 2008
- Dramatic drop for Korean M&A Oct 10 2008
- Cashbox takes Cash4All Oct 10 2008
- Louche London acquires Joy Oct 09 2008
M & A Events
- How to Float on AIM 11th November
- M&A Awards 2009 18th February
Business Diary
- M&A Expanding internationally 27th November
- Rosenblatt New Energy Awards 2009 25th February
- Business XL How to float on AIM 11th November